A NEW HOPE FOR CANCER TREATMENT...the CYTOTRON Machine
More than 1,300 persons are succumbing to cancer every day. Cancer is a complicated disease that needs to be demystified. People fear the disease and many believe it is unbeatable.
As per data of the National Cancer Registry Programme of the India Council of Medical Research (ICMR), the estimated mortality rate due to cancer saw an increase of six per cent approximately between 2012 and 2014.
CYTOTRON is a new, gentle, safe, non-invasive hope for millions of cancer tumor patients faced with death or the dreaded side effects of conventional treatments.
CYTOTRON is a State-of-the-Art Therapeutic Device based on Rotational Field Quantum Magnetic Resonance (RFQMR) which utilizes highly complex electromagnetic beams in the radio frequency spectrum controlled by a computer and guided by MRI.
The beams are precisely controlled and focused onto tissues to alter the cell membrane potential of the target tissue cells which in turn stimulates cartilage growth in case of degenerative diseases such as Osteoarthritis or triggers the programmed cell death and stops the tumor's growth in Cancer.
Cytotron is the trade name of the device developed by Centre for Advanced Research and Development (CARD) - a division of Scalene Cybernetics Limited in Bengaluru, India.
Cytotron looks like a MRI machine and is the world's first Rotational Field Quantum Magnetic Resonance (RFQMR) Generator for Tissue Regeneration, Degeneration and Repair for treating several chronic or degenerative diseases such as Cancer & Arthritis. The treatment is non-invasive, painless and free from side effects. Clinical studies have demonstrated that Cytotron is very effective in treating certain conditions such as a damaged knee by regenerating the cartilage tissue or stopping and reversing the growth of a tumor in cancer.
What exactly is Tissue Engineering?
Tissue Engineering is the field of altering, modifying, controlled reproduction and controlled regeneration and degeneration of biological tissue. Using Tissue engineering techniques, today it is possible to regenerate dying tissues and organs inside the body, grow new blood vessels, heal wounds or fix an adamant fracture, grow new cartilage or even teach a few lessons to cancerous cells that go into a multiplication spree.
Arresting cell growth with RFQMR
RFQMR technology utilizes a totally different approach compared to conventional cancer treatments. Instead of the very high frequency ionizing radiation used in radiotherapy, RFQMR uses radio or sub-radio frequency, low power, non-ionizing, non-thermal electromagnetic waves.
The main concern of the therapy is not the immediate destruction of the cancer cells, but rather with the help of the small amount of energy provided to the cell to stop the DNA's uncontrolled mitosis, put the cell in a vegetative state and in time through apoptosis mechanism let the body get rid of the cancerous cells in a controlled fashion.
Manufactured in India, widely accepted Internationally
Cytotron has international patent, manufactured in India, in compliance with ISO 9001:2000 and ISO 13485:2003. It has obtained CE Certificate marking European Conformity for safety, public health and consumer protection and has qualified for CMDCAS, Canada's Health regulatory requirements making it acceptable in Europe and Canada for tissue regeneration and degeneration.
FAQs on CYTOTRON
What results have been obtained with Cytotron?
A phase 1 clinical study has been held at the Institute of Aerospace Medicine in India between 2004 and 2006 on more than 100 terminal cancer patients. All patients had undergone all possible conventional interventions such as chemo, radiotherapy or surgery prior to RFQMR and yet the disease cannot be controlled and they are supposed to die within a few days to few months due to cancer. Out of such patients:
-> There is a 90% symptomatic relief (such as ease of pain, stop using pain killers, no more weight loss etc)
-> In most of the patients the tumor progression is stopped or reversed
-> More than 60% survived more than 1 year
-> More than 35 % went back to normal lives and living disease free for 2 years
-> As all of those patients were terminal cases that had exhausted all other treatments, the outcomes of the Cytotron therapy is outstanding.
It is believed that in patients who are in a non-terminal situation (in better overall condition, with stronger immune system and has not been subject to the toxic conventional therapies with side effects) the efficacy of Cytotron will be even more pronounced.
What are the advantages of Cytotron therapy?
Cytotron Therapy has the following advantages:
¨ Purely external with beam of rays.
¨ No anesthesia, cut, scar, blood transfusion.
¨ No pain of treatment.
¨ Usually no hospitalization.
¨ No treatment complications or infection.
¨ Possible in surgery unfit patients.
¨ Well accepted by aware doctors and patients
¨ Cost effective.
How does RFQMR work in Tissue Degeneration of the tumor?
In Degenerative RFQMR, like in the application of destruction of the tumor in a cancer patient, it is thought that the chromosomes, following the messages received as a result of the variations of potential (-70 to -90mV normal, -40 to -60 when infected, -20 to -30 in cancer and 0 when dead) in the cytoplasmic membrane, activate through electromechanical effects (stress responsive), the emission of messages by the genes that regulate cell dynamics for normal cell functions or for the mitochondrial activities for ATP production.
It is supposed that the excessive production of ATP is related to an alteration of the glycoproteinic sensors present on the mitochondrion membrane with consequent lowering of the impedance that in turn does not discriminate between the signals in frequency and activates the production of ATP in an almost continual way. The cancer cell would therefore go into mitosis due to the excess of ATP. RFQMR fields are used to act on the mitochondrial membrane, increasing the impedance of the glycoproteinic sensors through the lengthening of the polyglycidic chain. The spin of the RFQMR field is used to interfere with the communications between the genes and the protoplasmic glycoproteinic complexes involved in the promotion of cell mitosis.
By this the impedance of the mitochondrial membrane to the messages coming from the genes increase with the RFQMR treatment and with increase in the malignancy (the highest impedance for undifferentiated tumors). This is related to a greater alteration of the sensors of the undifferentiated tumors and therefore to their greater predisposition to the bond with polyglycidic chains. The undifferentiated cancer cells, because of the high impedance induced on the mitochondrial membrane by the RFQMR treatment, it stops producing ATP and therefore 'possibly' enter into apoptosis. Following the treatment the differentiated cancer cells have an impedance which is still sensitive to some messages coming from the chromosomes promoting the normal production of ATP, so these cells change their state of mitosis; however, they continue to live in a quiescent state (vegetative form of life). The normal cells are not influenced by the RFQMR radiation treatment as the impedance of their mitochondrial sensors is not modified and remain sensitive to messages that arrive from the chromosomes for the activation of the ATP synthesis.
What cancers can be treated with Cytotron?
Cytotron can treat all tumors such as brain, breast, cervix, bladder, colon, rectum, lymphomas, liver, lung, ovary, pancreas, kidney, stomach, uterus, prostate, etc. both for primary tumors and for metastasis.
Is Cytotron possible along with other treatments?
Yes, Cytotron therapy is possible before, with or after Radiotherapy, Chemotherapy, Surgery, etc. In patients who have surgery etc. before Cytotron we suggest having a Cytotron protocol MRI before the treatments to enable Cytotron dose planning for treatment to decrease the chance of recurrence.
Is Cytotron still experimental?
No, Cytotron to treat Musculoskeletal Disorders and terminal Cancer patients is not experimental as all required technical, safety and clinical requirements have been fulfilled and results published.
The Inventor of CYTOTRON
The team that developed Cytotron after years of research at SCALENE CENTER FOR ADVANCED RESEARCH AND DEVELOPMENT, Bengaluru, India, is headed by Dr Rajah Vijay Kumar DSc. Dr Kumar is a pioneering researcher and an opinion leader in the field of Biophysics and Radiobiology. Specialized in Medical Engineering, he has worked for more than fifteen years on regenerative tissue engineering and high speed biological data acquisition, modeling and simulation of the human cardiovascular system. The many patents held by him include the Realistic Geometry Cartographic Imaging (RGCI) / Cardiovascular Cartography (3DCCG) which finds applications from medical science to tsunami detection, and the Cytotron which is considered an important milestone in radiobiology and tissue engineering. His work on Nanotechnology has sparked off a new technique in selective tissue destruction with a "nanoblaster" that is undergoing laboratory trials. His inventions in the Water field like Hypersonic Precipitation and Fine Particle Shortwave Thrombolytic Agglomeration Reactor [FPSTAR] will redefine the Water and Waste Water industry world over.